Division of AIDS, Center for Immunology and Pathology, National Institute of Health, Korea Centers for Disease Control and Prevention, Seoul, Korea.
Virol J. 2010 Aug 25;7:201. doi: 10.1186/1743-422X-7-201.
We investigated the prevalence of human papillomavirus (HPV) infection and the distribution of high-risk HPV genotypes among 2,308 high-risk Korean women to predict how much the current prophylactic HPV vaccines might affect the prevention of cervical cancer in Korea. HPV DNA was detected in 939 women (40.7%) but only one-third of women were positive for HPV-16 and/or HPV-18, the genotypes used for developing the HPV vaccines. Thus, the development of area-specific HPV vaccines based on dominant HPV genotypes in our country is needed for preventing HPV infection and the development of premalignant lesions in the cervix of Korean women.
我们调查了 2308 名韩国高危女性人群中人类乳头瘤病毒(HPV)感染的流行情况和高危型 HPV 基因型的分布,以预测当前预防性 HPV 疫苗对韩国宫颈癌预防的影响程度。HPV DNA 在 939 名女性中被检测到(40.7%),但只有三分之一的女性 HPV-16 和/或 HPV-18 呈阳性,HPV 疫苗就是基于这两种基因型研发的。因此,为了预防 HPV 感染和韩国女性宫颈前病变的发展,需要根据我国主要 HPV 基因型开发特定区域的 HPV 疫苗。